EUVIMEDEUVIMED entdecken
Crossref

Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis

Angel George iD, Anns Mariya iD, Manu Eappen iD, Marimuthu Karthikeyan iD, Ravindranath Sreenath

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Angel George und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha, Ernakulam, Kerala 686661, India. Hauptthemen laut MEDLINE: Graves Disease, Biomarkers, Phosphoric Diester Hydrolases, Thyroiditis. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recent studies have suggested that serum autotaxin (ATX) may be a promising diagnostic biomarker in differentiating between Graves’ disease (GD) and thyroiditis, as well as serving as a monitoring biomarker for GD. This study will evaluate the use of serum ATX as a diagnostic biomarker in these conditions.

Methods

In this prospective interventional study, blood samples were collected from the patients who met both inclusion and exclusion criteria, and serum ATX levels were measured by using the MyBioSource human Autotaxin ELISA kit.

Results

A total of 32 patients were enrolled, of which 18.8% were newly diagnosed with GD, 21.9% were thyroiditis, and 59.3% were on treatment for GD. Serum autotaxin antigen was significantly higher in GD patients than in thyroiditis (603.3217 ± 444.24 v/s 214.74 ± 55.91, P = <.005). Serum ATX measurement successfully discriminated GD patients from thyroiditis (AUC = 0.952, 95%CI: 0.00–1.00) with an optimal cutoff value of ≥257.20 ng/L (sensitivity = 100 and specificity = 81.71). Monitoring the efficacy of serum ATX was analyzed and showed a significant difference.

Conclusion

The serum ATX was higher in subjects with GD as compared to thyroiditis, and ATX levels were found to be decreased during the treatment period. In conclusion, serum ATX can be used as a diagnostic and monitoring biomarker in GD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graves DiseaseBiomarkersPhosphoric Diester HydrolasesThyroiditisHumansFemaleMaleAdultProspective StudiesMiddle AgedDiagnosis, DifferentialSensitivity and SpecificityYoung AdultAgedLysophospholipase D

Stichwörter der Autor:innen

Graves’diseaseautotaxinbiomarkerthyroiditis

Substanzen

BiomarkersPhosphoric Diester HydrolasesLysophospholipase D

Autor:innen und Institutionen

  • Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha, Ernakulam, Kerala 686661, India.
  • Department of Pharmacology, Grace College of Pharmacy, Palakkad, Kerala 678004, India.
  • Department of Endocrinology, Caritas Hosptial, Thellakom, Kottayam 686630, India.

ORCID-Profile: Angel George, Anns Mariya, Manu Eappen, Marimuthu Karthikeyan

Zitieren

APA

George, A., Mariya, A., Eappen, M., Karthikeyan, M., & Sreenath, R. (2025). Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae073

Vancouver

George A, Mariya A, Eappen M, Karthikeyan M, Sreenath R. Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae073

BibTeX
@article{George2025,
  author = {George, Angel and Mariya, Anns and Eappen, Manu and Karthikeyan, Marimuthu and Sreenath, Ravindranath},
  title = {Serum autotaxin level: a promising diagnostic biomarker in differentiating Graves’ disease and thyroiditis},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae073}
}
Kostenlos starten →